Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses-Reference-Cited by-同舟云学术

Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses

Published:2020-12 Issue:6 Volume:53 Page:1315-1330.e9
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Ma Xiancai,Zou Fan,Yu Fei,Li Rong,Yuan Yaochang,Zhang Yiwen,Zhang Xiantao,Deng Jieyi,Chen Tao,Song Zheng,Qiao Yidan,Zhan Yikang,Liu Jun,Zhang Junsong,Zhang Xu,Peng Zhilin,Li Yuzhuang,Lin Yingtong,Liang Liting,Wang Guanwen,Chen Yingshi,Chen Qier,Pan Ting,He Xin,Zhang Hui

Funder

National Special Research Program of China for Important Infectious Diseases

Special 2019-nCoV Program of Natural Science Foundation of China

Special 2019-nCoV Project of National Key Research and Development Program of China

Special 2019-nCoV Project of Research and Development Program of Guangdong

Important Key Program of NSFC

Joint-innovation Program in Healthcare for Special Scientific Research Projects of Guangzhou

the National Postdoctoral Program for Innovative Talents and the General Program of China Postdoctoral Science Foundation

Pearl River S&T Nova Program of Guangzhou

Publisher

Elsevier BV

Subject